Title of article :
Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial
Author/Authors :
Jean-Claude Tardif، نويسنده , , John J.V. McMurray، نويسنده , , Eric Klug، نويسنده , , Robert Small، نويسنده , , Jennifer Schumi، نويسنده , , Jasmine Choi، نويسنده , , Jim Cooper، نويسنده , , Robert Scott، نويسنده , , Eldrin F Lewis، نويسنده , , Philippe L LʹAllier، نويسنده , , Marc A Pfeffer، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 2008
Pages :
8
From page :
1761
To page :
1768
Abstract :
Background Oxidative stress and inflammation are involved in the pathophysiology of atherosclerosis. Our aim was to assess the effects of the antioxidant succinobucol (AGI-1067) on cardiovascular outcomes in patients with recent acute coronary syndromes a
Journal title :
The Lancet
Serial Year :
2008
Journal title :
The Lancet
Record number :
592923
Link To Document :
https://search.isc.ac/dl/search/defaultta.aspx?DTC=10&DC=592923
بازگشت